Description
Tesamorelin functions as a synthetic analog of growth hormone-releasing hormone (GHRH), stimulating the pituitary gland to release endogenous growth hormone (GH), which in turn increases insulin-like growth factor-1 (IGF-1) levels.
This mechanism enhances fat metabolism and specifically targets visceral adipose tissue, leading to significant reductions in deep abdominal fat, which is linked to metabolic disease and inflammation.
Ipamorelin is a synthetic peptide that mimics the action of ghrelin, a natural hormone, and stimulates the body to release its own growth hormone (GH) in a controlled and pulsatile manner.
This targeted release supports a range of physiological benefits without significantly increasing cortisol, prolactin, or other unwanted hormones, making it one of the safer growth hormone secretagogues available.






